Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
Human medicines: European public assessment reports (EPARs)
Get the latest updates from Human medicines: European public assessment reports (EPARs) directly as they happen.
Follow now 279 followers
Latest posts
Last updated about 1 hour ago
Human medicines European public assessment report (EPAR): Takhzyro, lanadelumab, Date of authorisation: 22/11/2018, Revision: 22, Status: Authorised
about 1 hour ago
Human medicines European public assessment report (EPAR): Takhzyro, lanadelumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Thalidomide Lipomed, thalidomide, Date of authorisation: 19/09/2022, Revision: 2, Status: Authorised
about 1 hour ago
Human medicines European public assessment report (EPAR): Thalidomide Lipomed, thalidomide, Date of...
Human medicines European public assessment report (EPAR): Locametz, gozetotide, Date of authorisation: 09/12/2022, Revision: 7, Status: Authorised
about 1 hour ago
Human medicines European public assessment report (EPAR): Locametz, gozetotide, Date of authorisation...
Human medicines European public assessment report (EPAR): Otulfi, ustekinumab, Date of authorisation: 25/09/2024, Revision: 3, Status: Authorised
4 days ago
Human medicines European public assessment report (EPAR): Otulfi, ustekinumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Loqtorzi, toripalimab, Date of authorisation: 19/09/2024, Revision: 2, Status: Authorised
4 days ago
Human medicines European public assessment report (EPAR): Loqtorzi, toripalimab, Date of authorisation...
Human medicines European public assessment report (EPAR): Champix, varenicline, Date of authorisation: 25/09/2006, Revision: 39, Status: Authorised
4 days ago
Human medicines European public assessment report (EPAR): Champix, varenicline, Date of authorisation...
Human medicines European public assessment report (EPAR): Rukobia, fostemsavir, Date of authorisation: 04/02/2021, Revision: 6, Status: Authorised
4 days ago
Human medicines European public assessment report (EPAR): Rukobia, fostemsavir, Date of authorisation...
Human medicines European public assessment report (EPAR): Menveo, meningococcal group A, C, W-135 and Y conjugate vaccine, Date of authorisation: 15/03/2010, Date of refusal: 17/12/2009, Revision: 37, Status: Authorised
4 days ago
Human medicines European public assessment report (EPAR): Menveo, meningococcal group A, C...
Human medicines European public assessment report (EPAR): Dectova, zanamivir, Date of authorisation: 26/04/2019, Revision: 7, Status: Authorised
4 days ago
Human medicines European public assessment report (EPAR): Dectova, zanamivir, Date of authorisation...
Human medicines European public assessment report (EPAR): Ryjunea, atropine sulfate, Date of authorisation: 02/06/2025, Status: Authorised
4 days ago
Human medicines European public assessment report (EPAR): Ryjunea, atropine sulfate, Date of...
Human medicines European public assessment report (EPAR): Hexyon, diphtheria, tetanus, pertussis (acellular, component), hepatitis B (rDNA), poliomyelitis (inactivated) and Haemophilus influenzae type b conjugate vaccine (adsorbed), Date of authorisation:
5 days ago
Human medicines European public assessment report (EPAR): Hexyon, diphtheria, tetanus, pertussis (acellular...
Human medicines European public assessment report (EPAR): Hexacima, diphtheria, tetanus, pertussis (acellular, component), hepatitis B (rDNA), poliomyelitis (inactivated) and Haemophilus influenzae type b conjugate vaccine (adsorbed), Date of authorisatio
5 days ago
Human medicines European public assessment report (EPAR): Hexacima, diphtheria, tetanus, pertussis (acellular...